Indications

PRESS RELEASES

Press Releases

Antengene Announces XPOVIO® (selinexor) Approved for Its Third Indication in South Korea, Bringing Fresh Hope to Patients with MM in the Country

October 18, 2024

·

5 min read

Press Releases

Allogene Therapeutics to Present Pre-Clinical Data Highlighting the Potential of ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Diseases, at the American College of Rheumatology (ACR) Convergence

September 27, 2024

·

6 min read

Press Releases

Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress

September 27, 2024

·

11 min read